drugset / Trial / NCT06800092
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
RandomizedParallel-groupOpen-labelSupportive care
Summary
This study is examining the effects of standard of care cancer treatment as well as a medication called Sildenafil, on the cancer associated fatigue, cognition and the gut microbiome.
Timeline
- Start
- 2027-06-15
- Primary completion
- 2030-06-01
- Completion
- 2030-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 50 mg | — |